Research
Hormonal
Combined diet and exercise interventions during pregnancy do not clearly reduce the risk of pre-eclampsia compared to standard care.
While combining diet and exercise during pregnancy is beneficial for preventing gestational diabetes and may help with caesarean section rates, current evidence does not show it clearly prevents pre-eclampsia. Continue to follow your healthcare provider's advice for managing blood pressure and other pregnancy risks.
LimitedRefutesLOW confidence
No clear differences were seen between groups for pre-eclampsia (RR 0.98, 95% CI 0.79 to 1.22; 5366 participants; 8 RCTs; low-quality evidence).
Why this rating
Low-quality evidence per GRADE, limited by risk of bias and heterogeneity.
Source
Combined diet and exercise interventions for preventing gestational diabetes mellitus
Emily Shepherd et al. · Cochrane Database of Systematic Reviews · 2017
DOI 10.1002/14651858.cd010443.pub3
Meta-analysis · 23 studiesCited 241×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Combined diet and exercise interventions during pregnancy reduce the risk of developing gestational diabetes mellitus (GDM) compared to standard care alone, with moderate-quality evidence showing a possible reduction in risk (RR 0.85).Moderate
- Combined diet and exercise interventions during pregnancy may reduce the risk of caesarean section compared to standard care, with moderate-quality evidence.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →